⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AEMD News
AETHLON MEDICAL INC
Form 8-K
sec.gov
AEMD
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
prnewswire.com
AEMD
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
prnewswire.com
AEMD
Exosome Therapy Market Size and Industry Dynamics 2026-2035 - Standardization Challenges Loom Over Booming $58 Billion Exosome Therapy Industry
globenewswire.com
CRBP
CAPR
AEMD
COYA
EVOX
Presenting on Emerging Growth Conference 91 Day 2 on April 2; Register to live stream
globenewswire.com
NB
DGXX
VGZ
NWTG
NVA
OSRH
FET
TIVC
MIGI
AEMD
BESS
ATCH
VWAV
JUNS
CIA
Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live stream
globenewswire.com
DGXX
NB
NVA
OSRH
PDC
TIVC
VGZ
JUNS
NWTG
VWAV
BESS
FET
MIGI
CIA
ATCH
AEMD
Advancements in Novel Immunotherapeutics in The Oncology Battle Ready to Announce with Confidence?
newsfilecorp.com
AEMD
HURA
AZN
ELTX
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
prnewswire.com
AEMD
Form 8-K
sec.gov
AEMD
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
globenewswire.com
JUNS
DYAI
PHIO
CVKD
TNXP
MTVA
XAIR
AEMD
NSRX
ICU
JAGX